Applications for up to £20,000 to pump-prime innovative, high-risk and proof-of-concept Oxford-based immuno-oncology research are welcomed. Successful applications should:
- demonstrate genuine integration of immunology and cancer research;
- demonstrate clear line of sight to translation;
- be informed by patient and public involvement;
- increase Oxford’s immuno-oncology capacity;
- be used to leverage follow-on external funding.
Please find more information here. The deadline is midday Friday 12th September.